Patient Subsidy System Expanded for Intractable Diseases, What about Incentives for Drug Makers?

April 7, 2015
A health ministry committee approved the granting of “designated intractable diseases” status to 196 diseases on March 19 as a second batch of diseases to be covered by a new medical subsidy system launched in January. Patients treated for these...read more